Company Results2 Min Read InvestyWise NewsonNovember 14, 2025 HLV Limited Q2 Financial Results, Leadership Changes Announced HLV Limited announced its unaudited financial results for the second quarter ended September 30, 2025. The board approved the results and also…
Board Meeting2 Min Read InvestyWise NewsonNovember 14, 2025 HLV Limited Board Approves Unaudited Q2 Results, Appoints New Company Secretary HLV Limited’s board has approved the unaudited financial results for Q2 (Jul-Sep) and the half-year ended September 30, 2025. The board…
Company Update1 Min Read InvestyWise NewsonNovember 14, 2025 NMDC Limited Board Declares No Interim Dividend for FY26 The Board of Directors of NMDC Limited has decided not to declare an interim dividend on the equity shares of the company for the fiscal year…
Corporate Action1 Min Read InvestyWise NewsonNovember 14, 2025 Natco Pharma Declares Interim Dividend of ₹1.50 Per Share Natco Pharma has declared an interim dividend of ₹1.50 (Rupees One and paise fifty only) per equity share. This dividend, representing 75%, is…
Company Update1 Min Read InvestyWise NewsonNovember 14, 2025 Zydus Lifesciences Receives USFDA Approval for Leuprolide Acetate Injection Zydus Lifesciences has received final approval from the USFDA for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial.…
Company Results1 Min Read InvestyWise NewsonNovember 14, 2025 NATCO Pharma Reports ₹1,463 Crore Revenue, Approves Interim Dividend NATCO Pharma (NATCOPHARM) announced its Q2 FY26 results, reporting a consolidated total revenue of ₹1,463.0 Crore, up from ₹1,434.9 crore in…
Company Results1 Min Read InvestyWise NewsonNovember 14, 2025 Gujarat Mineral Development Corporation Reports Unaudited Financial Results for Q2 2026 Gujarat Mineral Development Corporation (GMDC) has announced its unaudited standalone and consolidated financial results for the quarter ended…
Corporate Action1 Min Read InvestyWise NewsonNovember 14, 2025 Natco Pharma Declares Interim Dividend of ₹1.50 Per Equity Share Natco Pharma has declared an interim dividend of ₹1.50 (Rupees One and paise fifty only) per equity share of ₹2 each for the financial year…
Board Meeting1 Min Read InvestyWise NewsonNovember 14, 2025 NATCO Pharma Q2FY26 Revenue at ₹1,463 Crore, Interim Dividend Declared NATCO Pharma (NATCOPHARM) announced its Q2FY26 results, reporting a consolidated total revenue of ₹1,463.0 Crore, compared to ₹1,434.9 crore…
Company Update1 Min Read InvestyWise NewsonNovember 14, 2025 Info Edge Acquires Remaining Stake in Aisle, Takes Full Control Info Edge has increased its stake in Aisle Network Private Limited by acquiring the remaining 3.65% of its paid-up share capital for ₹5.50…